Single-Session Lung Cancer Diagnosis, Staging

How Can Lung Cancer Diagnosis and Surgery Be Combined?

A conventional lung cancer pathway may require separate appointments for bronchoscopy or needle biopsy, mediastinal lymph-node staging, localization of a small nodule and surgery. The proposed single-session model brings these steps together in a suitably equipped operating room. Navigational or robotic bronchoscopy can help clinicians reach peripheral lung nodules, while endobronchial ultrasound can sample lymph nodes that may contain cancer.

If rapid pathological assessment confirms a resectable malignancy and nodal findings do not indicate a need to change course, surgeons may proceed with video-assisted or robot-assisted thoracic surgery. A bronchoscopically placed dye or marker can help locate small or deeply situated nodules that are difficult to see or feel from the lung surface. The exact operation may range from a limited resection to lobectomy, depending on tumor characteristics, lung function and established cancer-surgery principles.

What Benefits Could a Single-Session Procedure Offer?

For patients, the clearest potential advantage is a more coordinated pathway. Completing several steps during one encounter may reduce travel, scheduling delays and the anxiety of waiting between tests. It could also avoid a separate localization procedure immediately before surgery and limit the number of times a patient must stop medications, fast or recover from sedation.

The approach may also preserve diagnostic accuracy by allowing specialists to select the appropriate sampling and staging tools in real time. However, faster care is not automatically better care: treatment should not proceed until the team has enough information to determine whether surgery is appropriate. Multidisciplinary review, informed consent and contingency planning remain essential, particularly when rapid pathology is inconclusive or lymph-node sampling changes the suspected stage.

Who May Be Eligible for Combined Lung Cancer Procedures?

Eligibility depends on the lesion's location, estimated probability of cancer, imaging findings, lymph-node appearance, pulmonary reserve and the patient's overall health. Surgical resection remains an important curative-intent treatment for medically operable early-stage non-small cell lung cancer, but not every lung nodule requires immediate biopsy or surgery. Some nodules can be monitored with repeat imaging, while others may be better evaluated using percutaneous biopsy or a different bronchoscopic technique.

Patients with advanced disease, significant surgical risk or findings suggesting that systemic therapy should come first may need another pathway. Stereotactic body radiation therapy is an established option for many patients with early-stage disease who cannot undergo surgery. Because the combined procedure requires advanced imaging, bronchoscopy, thoracic surgery and pathology services to work together, it may initially be available mainly at specialized centers.